Study on apo A-IV polymorphism in patients with hyperlipidemia.
Study on apo A-IV polymorphism in patients with hyperlipidemia.
批准号:
07672485
负责人:
SEISHIMA Mitsuru
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We compared the frequencies of apo A-IV polymorphism at codon 347 and 360 in 40 hyperlipidemic patients with 131 healthy controls. All healthy controls and hyperlipidemic patients studied here had Thr/Thr at codon 347. This result was different with a report in Western, which showed the frequency of Ser allele was 0.144 to 0.216. On the other hand, the frequency of Gln/llis at codon 360 in hyperlipidemic patients was 17.5%, which was lower than 22% in controls although there was no statistical difference between them. It is well known that Gln/Gln and His/His at codon 360 are corresponded to A-IV-1 and A-IV-2, respectively at protein level. It has been reported that subjects with A-IV-2 show higher HDL-C and LCAT activity compared to those with A-IV-1.In addition, A-IV-2 regulates cholesterol absorbtion in the small intestine. These isoforms, thus, have different functions in the lipid metabolism. In view of this point, few frequency of Gln/His (A-IV-2) in hyperlipidemic patients may indicate that this varient is associated with the cause for hyperlipidemia. However, in the present study, we could not find the difference in the frequency of apo A-IV polymorphism among subtypes of hyperlipidemia, but further study will be necessary in large scale of number.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Seishima, M. et al.: "Reduced intestinal apo A-IV mRNA levels in patienta with liver cirrhosis" Int. Hepatol. Commun.4. 153-159 (1995)
Seishima, M. 等人:“肝硬化患者肠道 apo A-IV mRNA 水平降低”Int。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura, M.et al.: "Effects of lipid administration on lymphatic apolipoprotein A-IV and B output and synthesis" Am.J.Physiol.271. 322-329 (1996)
Nishimura, M.等人:“脂质给药对淋巴载脂蛋白 A-IV 和 B 输出和合成的影响”Am.J.Physiol.271。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seishima, M.et al.: "Reduction of intestinal apo A-IV mRNA levels in the cirrhoticrat" J.Hepatol.Gastroenterol.11. 746-751 (1996)
Seishima, M.et al.:“肝硬化大鼠肠道 apo A-IV mRNA 水平的降低”J.Hepatol.Gastroenterol.11。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seishima, M. et al.: "Reduction of intestinal apo A-IV mRNA levels in the cirrhotic rat" J. Hepatol. Gastroenterol.11. 746-751 (1996)
Seishima, M. 等人:“肝硬化大鼠肠道 apo A-IV mRNA 水平的降低”J. Hepatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seishima, M.et al.: "Reduced intestinal apo A-IV mRNA levels in patients with liver cirrhosis" Int.Hepatol.Commun. 4. 153-159 (1995)
Seishima, M.et al.:“肝硬化患者肠道 apo A-IV mRNA 水平降低”Int.Hepatol.Commun。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
The role of IDO in the HBV-related liver diseases.
-
批准号:24659361
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Screening and gene analysis for the protection from muscle damage by statin drugs
-
批准号:21390179
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2009
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Study on analytical system for the etiology of autoimmune disease using two-dimensional nano LC/MS
-
批准号:17390161
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.93万
-
财政年份:2005
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Study on the mechanism of atherosclerotic lesion formation using cytokine-knockout mouse
-
批准号:13470517
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2001
-
负责人:SEISHIMA Mitsuru
-
依托单位:
The method for determination of serum lipid-free apolipoprotein concentration and its clinical application
-
批准号:11557204
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:1999
-
负责人:SEISHIMA Mitsuru
-
依托单位:
The mechanism for synthesis and secretion of apo A-IV in CaCo-2 cells
-
批准号:09672353
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:SEISHIMA Mitsuru
-
依托单位:
海外基金